VTVT earnings date and last-quarter result: last quarter beat, P/E 1583.50. Updated 2026-07-23.
vTv Therapeutics (VTVT) Research Hub
vTv Therapeutics (VTVT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 25.81 USD (+1.02%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 1583.50, market cap 0.08B. This hub links to the full technical, earnings and options research available for VTVT.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 25.81 USD (+1.02%) |
| 52-week range | 25.55 USD – 38.84 USD |
| Trend regime | Range |
| 14-day RSI | 31.9 (Bearish) |
| Trailing P/E | 1583.50 |
| Market cap | 0.08B |
| Dividend yield | 0.00% |
Available research for VTVT
Covered Call on VTVT: how it works, illustrative setup around the real 25.81 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on VTVT: how it works, illustrative setup around the real 25.81 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on VTVT: how it works, illustrative setup around the real 25.81 USD price, max profit/loss, breakeven and when to use it. Educational.
VTVT technical analysis: range, last 25.81 USD, RSI 31.9, 52w range 25.55 USD–38.84 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is VTVT in?
vTv Therapeutics (VTVT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is VTVT in an uptrend or downtrend?
As of 2026-10-26, VTVT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is VTVT's trailing P/E ratio?
VTVT's trailing P/E is 1583.50, with a market cap of 0.08B. See the earnings research page for full valuation detail.